InvestorsHub Logo
Followers 27
Posts 2828
Boards Moderated 0
Alias Born 02/24/2014

Re: Herb Tarlek post# 43608

Saturday, 10/22/2016 12:33:00 AM

Saturday, October 22, 2016 12:33:00 AM

Post# of 128759
It eliminated arguably one of the 3 biggest competitors and actually tweed was struggling with strains and quality and consistency then....which I believe bedrocan made a big difference with long before DNA genetics.

Also, we have the rights to bedrocan in the U.S. & South America - so one day CGC will not have to compete with them down the road either but will get to capitalize on any proprietary strains that they develop in Europe through clinical trials.